InsiderTrades.com logo

CLNN Insider Trading

Insider Ownership Percentage: 28.30%
Insider Buying (Last 12 Months): $216,664.50
Insider Selling (Last 12 Months): $5,187,643.28

Clene Insider Trading History Chart

This chart shows the insider buying and selling history at Clene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Clene Share Price & Price History

Current Price: $3.83
Price Change: +0.30 (1.20%)
As of 10/30/2026 04:00 PM ET

This chart shows the closing price history over time for CLNN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Clene Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2026Chidozie UgwumbaMajor ShareholderSell73,296$6.20$454,435.20103,417View SEC Filing Icon  
5/11/2026Chidozie UgwumbaMajor ShareholderSell22,177$6.75$149,694.75176,713View SEC Filing Icon  
5/4/2026Chidozie UgwumbaMajor ShareholderSell72,884$6.80$495,611.20198,890View SEC Filing Icon  
5/1/2026Chidozie UgwumbaMajor ShareholderSell5,795$6.01$34,827.95271,774View SEC Filing Icon  
4/30/2026Chidozie UgwumbaMajor ShareholderSell5,736$6.08$34,874.88277,569View SEC Filing Icon  
4/29/2026Chidozie UgwumbaMajor ShareholderSell12,170$5.63$68,517.10283,305View SEC Filing Icon  
4/28/2026Chidozie UgwumbaMajor ShareholderSell1,591$5.90$9,386.90295,475View SEC Filing Icon  
4/21/2026Chidozie UgwumbaMajor ShareholderSell61,345$6.14$376,658.30297,066View SEC Filing Icon  
4/20/2026Chidozie UgwumbaMajor ShareholderSell4,318$6.12$26,426.16358,411View SEC Filing Icon  
4/17/2026Chidozie UgwumbaMajor ShareholderSell25,040$6.43$161,007.20362,729View SEC Filing Icon  
4/16/2026Chidozie UgwumbaMajor ShareholderSell7,748$6.40$49,587.20387,769View SEC Filing Icon  
4/15/2026Chidozie UgwumbaMajor ShareholderSell6,374$6.48$41,303.52395,517View SEC Filing Icon  
4/2/2026Chidozie UgwumbaMajor ShareholderSell24,925$4.81$119,889.25401,891View SEC Filing Icon  
4/1/2026Chidozie UgwumbaMajor ShareholderSell4,278$4.97$21,261.66426,816View SEC Filing Icon  
2/3/2026Chidozie UgwumbaMajor ShareholderSell5,559$4.10$22,791.90550,000View SEC Filing Icon  
2/2/2026Chidozie UgwumbaMajor ShareholderSell3,800$4.04$15,352.00555,559View SEC Filing Icon  
1/30/2026Chidozie UgwumbaMajor ShareholderSell5,686$4.13$23,483.18559,359View SEC Filing Icon  
1/29/2026Chidozie UgwumbaMajor ShareholderSell15,284$4.32$66,026.88565,045View SEC Filing Icon  
1/28/2026Chidozie UgwumbaMajor ShareholderSell8,717$4.91$42,800.47580,329View SEC Filing Icon  
1/27/2026Chidozie UgwumbaMajor ShareholderSell4,139$5.08$21,026.12589,046View SEC Filing Icon  
1/26/2026Chidozie UgwumbaMajor ShareholderSell6,418$5.02$32,218.36593,185View SEC Filing Icon  
1/23/2026Chidozie UgwumbaMajor ShareholderSell5,556$5.27$29,280.12599,603View SEC Filing Icon  
1/22/2026Chidozie UgwumbaMajor ShareholderSell12,665$5.32$67,377.80605,159View SEC Filing Icon  
1/21/2026Chidozie UgwumbaMajor ShareholderSell12,119$5.05$61,200.95617,824View SEC Filing Icon  
1/20/2026Chidozie UgwumbaMajor ShareholderSell12,432$4.80$59,673.60629,943View SEC Filing Icon  
1/16/2026Chidozie UgwumbaMajor ShareholderSell7,923$5.13$40,644.99642,375View SEC Filing Icon  
1/15/2026Chidozie UgwumbaMajor ShareholderSell12,563$5.10$64,071.30650,298View SEC Filing Icon  
1/14/2026Chidozie UgwumbaMajor ShareholderSell19,621$5.12$100,459.52662,861View SEC Filing Icon  
1/13/2026Chidozie UgwumbaMajor ShareholderSell26,105$4.89$127,653.45682,482View SEC Filing Icon  
1/13/2026David J MatlinDirectorBuy33,333$6.50$216,664.50477,824View SEC Filing Icon  
1/12/2026Chidozie UgwumbaMajor ShareholderSell32,705$5.50$179,877.50708,587View SEC Filing Icon  
1/9/2026Chidozie UgwumbaMajor ShareholderSell9,075$6.27$56,900.25741,292View SEC Filing Icon  
1/8/2026Chidozie UgwumbaMajor ShareholderSell3,195$6.09$19,457.55750,367View SEC Filing Icon  
1/7/2026Chidozie UgwumbaMajor ShareholderSell3,938$6.29$24,770.02753,562View SEC Filing Icon  
1/6/2026Chidozie UgwumbaMajor ShareholderSell3,111$6.04$18,790.44757,500View SEC Filing Icon  
1/5/2026Chidozie UgwumbaMajor ShareholderSell5,869$5.87$34,451.03760,611View SEC Filing Icon  
1/2/2026Chidozie UgwumbaMajor ShareholderSell4,015$5.73$23,005.95766,480View SEC Filing Icon  
12/31/2025Chidozie UgwumbaMajor ShareholderSell13,095$5.81$76,081.95770,495View SEC Filing Icon  
12/30/2025Chidozie UgwumbaMajor ShareholderSell4,138$6.03$24,952.14783,590View SEC Filing Icon  
12/29/2025Chidozie UgwumbaMajor ShareholderSell8,096$5.95$48,171.20787,728View SEC Filing Icon  
12/26/2025Chidozie UgwumbaMajor ShareholderSell3,350$6.32$21,172.00795,824View SEC Filing Icon  
12/24/2025Chidozie UgwumbaMajor ShareholderSell1,490$6.27$9,342.30799,174View SEC Filing Icon  
12/23/2025Chidozie UgwumbaMajor ShareholderSell6,831$6.27$42,830.37800,664View SEC Filing Icon  
12/22/2025Chidozie UgwumbaMajor ShareholderSell4,367$6.54$28,560.18383,201View SEC Filing Icon  
12/19/2025Chidozie UgwumbaMajor ShareholderSell5,582$6.45$36,003.90387,568View SEC Filing Icon  
12/18/2025Chidozie UgwumbaMajor ShareholderSell5,816$6.33$36,815.28393,150View SEC Filing Icon  
12/17/2025Chidozie UgwumbaMajor ShareholderSell2,884$6.61$19,063.24398,966View SEC Filing Icon  
12/16/2025Chidozie UgwumbaMajor ShareholderSell7,030$6.31$44,359.30401,850View SEC Filing Icon  
12/15/2025Chidozie UgwumbaMajor ShareholderSell10,580$6.49$68,664.20408,880View SEC Filing Icon  
12/12/2025Chidozie UgwumbaMajor ShareholderSell7,603$6.79$51,624.37419,460View SEC Filing Icon  
12/11/2025Chidozie UgwumbaMajor ShareholderSell10,907$6.81$74,276.67427,063View SEC Filing Icon  
12/10/2025Chidozie UgwumbaMajor ShareholderSell9,921$6.42$63,692.82437,970View SEC Filing Icon  
12/9/2025Chidozie UgwumbaMajor ShareholderSell15,031$5.95$89,434.45447,891View SEC Filing Icon  
12/8/2025Chidozie UgwumbaMajor ShareholderSell21,463$5.70$122,339.10462,922View SEC Filing Icon  
12/5/2025Chidozie UgwumbaMajor ShareholderSell37,235$5.94$221,175.90484,385View SEC Filing Icon  
12/4/2025Chidozie UgwumbaMajor ShareholderSell72,748$6.73$489,594.04521,620View SEC Filing Icon  
12/3/2025Chidozie UgwumbaMajor ShareholderSell56,577$7.86$444,695.22594,368View SEC Filing Icon  
8/21/2025General Resonance LlcMajor ShareholderSell3,401$5.34$18,161.34704,591View SEC Filing Icon  
5/27/2025General Resonance LlcMajor ShareholderSell420$2.45$1,029.00710,432View SEC Filing Icon  
3/18/2025General Resonance LlcMajor ShareholderSell1,333$4.45$5,931.85712,252View SEC Filing Icon  
9/30/2024David J MatlinDirectorBuy92,307$4.75$438,458.25444,491View SEC Filing Icon  
9/30/2024Mark MortensonInsiderBuy20,512$4.75$97,432.0028,949View SEC Filing Icon  
4/30/2024General Resonance LlcMajor ShareholderSell650$8.40$5,460.00766,335View SEC Filing Icon  
4/24/2024General Resonance LlcMajor ShareholderSell500$6.60$3,300.00767,485View SEC Filing Icon  
4/9/2024General Resonance LlcMajor ShareholderSell1,125$7.80$8,775.00771,410View SEC Filing Icon  
11/10/2023David J MatlinDirectorBuy12,500$8.20$102,500.00352,184View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

23.28% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLNN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Clene Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/30/2026Lunt Capital Management Inc.21,287$87K0.0%-59.3%0.164%Search for SEC Filing on Google Icon
3/12/2026PEAK6 LLC50,012$0.29M0.0%N/A0.461%Search for SEC Filing on Google Icon
2/16/2026PEAK6 LLC50,012$0.29M0.0%N/A0.461%Search for SEC Filing on Google Icon
2/13/2026State Street Corp29,801$0.18M0.0%+138.4%0.275%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc114,361$0.67M0.0%+668.6%1.054%Search for SEC Filing on Google Icon
2/12/2026SymBiosis Capital Partners LLC770,495$4.52M4.4%N/A7.101%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC82,079$0.48M0.0%+8.0%0.756%Search for SEC Filing on Google Icon
11/13/2025Scoggin Management LP250,000$1.51M0.2%+75.1%2.483%Search for SEC Filing on Google Icon
11/12/2025Lunt Capital Management Inc.52,260$0.32M0.1%+2.5%0.519%Search for SEC Filing on Google Icon
11/4/2025Jones Financial Companies Lllp5,000$29K0.0%N/A0.050%Search for SEC Filing on Google Icon
8/15/2025Scoggin Management LP142,750$0.56M0.1%+42.8%1.726%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC12,095$47K0.0%N/A0.146%Search for SEC Filing on Google Icon
7/28/2025Lunt Capital Management Inc.51,010$0.20M0.1%+71.2%0.617%Search for SEC Filing on Google Icon
4/23/2025Penn Davis Mcfarland Inc.11,000$34K0.0%N/A0.128%Search for SEC Filing on Google Icon
2/17/2025Fullcircle Wealth LLC13,023$69K0.0%N/A0.156%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC18,040$96K0.0%N/A0.217%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC65,112$0.35M0.0%+52.9%0.782%Search for SEC Filing on Google Icon
2/6/2025SBI Securities Co. Ltd.13,025$69K0.0%N/A0.158%Search for SEC Filing on Google Icon
1/22/2025Parsons Capital Management Inc. RI36,500$0.19M0.0%N/A0.437%Search for SEC Filing on Google Icon
10/24/2024Lunt Capital Management Inc.29,540$0.14M0.1%-95.0%0.431%Search for SEC Filing on Google Icon
10/21/2024Castleview Partners LLC12,783$59K0.0%N/A0.186%Search for SEC Filing on Google Icon
7/10/2024Csenge Advisory Group269,600$96K0.0%+131.2%0.210%Search for SEC Filing on Google Icon
1/26/2024Soltis Investment Advisors LLC109,517$32K0.0%-50.0%0.085%Search for SEC Filing on Google Icon
11/15/2023Worth Venture Partners LLC1,404,284$0.70M0.4%-5.3%1.094%Search for SEC Filing on Google Icon
11/15/2023Kepos Capital LP131,322$65K0.0%-22.8%0.102%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC500,000$0.25M0.1%+100.0%0.389%Search for SEC Filing on Google Icon
11/13/2023AIGH Capital Management LLC5,801,878$2.88M1.4%-2.3%4.518%Search for SEC Filing on Google Icon
11/8/2023Vivo Capital LLC2,645,338$1.40M0.2%-41.5%2.060%Search for SEC Filing on Google Icon
11/1/2023Csenge Advisory Group116,600$58K0.0%N/A0.091%Search for SEC Filing on Google Icon
10/11/2023AE Wealth Management LLC172,528$86K0.0%+208.5%0.134%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC250,000$0.22M0.1%N/A0.319%Search for SEC Filing on Google Icon
8/11/2023AWM Investment Company Inc.5,000,000$4.40M0.6%N/A6.378%Search for SEC Filing on Google Icon
7/17/2023Impact Partnership Wealth LLC55,928$49K0.0%N/A0.071%Search for SEC Filing on Google Icon
7/10/2023AE Wealth Management LLC55,928$49K0.0%N/A0.071%Search for SEC Filing on Google Icon
5/10/2023Condor Capital Management165,836$0.19M0.0%N/A0.214%Search for SEC Filing on Google Icon
2/13/2023Kepos Capital LP344,427$0.34M0.0%-13.9%0.467%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC1,100,000$3.08M0.4%N/A1.490%Search for SEC Filing on Google Icon
11/15/2022Kepos Capital LP400,000$1.12M0.1%-33.3%0.542%Search for SEC Filing on Google Icon
10/21/2022Morgan Jess S & Co. Inc.112,000$0.31M0.3%+28.4%0.176%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC70,000$0.18M0.0%-86.4%0.111%Search for SEC Filing on Google Icon
8/8/2022Oppenheimer & Co. Inc.32,026$81K0.0%+27.2%0.051%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Clene logo
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Read More on Clene

Today's Range

Now: $3.83
Low: $3.75
High: $3.95

50 Day Range

MA: $3.95
Low: $3.10
High: $4.65

52 Week Range

Now: $3.83
Low: $3.02
High: $13.50

Volume

47,081 shs

Average Volume

90,238 shs

Market Capitalization

$49.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Clene?

Clene's top insider shareholders include:
  1. Chidozie Ugwumba (Major Shareholder)
  2. General Resonance Llc (Major Shareholder)
  3. David J Matlin (Director)
  4. John Henry Stevens (Director)
  5. Mark Mortenson (Insider)
  6. Jonathon Gay (Director)
  7. Robert Dee Etherington (CEO)
  8. Alison Mosca (Director)
  9. David J Matlin (Director)
  10. Robert Glanzman (Insider)
Learn More about top insider investors at Clene.

Who are the major institutional investors of Clene?

Clene's top institutional shareholders include:
  1. Lunt Capital Management Inc. — 0.16%
Learn More about top institutional investors of Clene stock.

Which institutional investors are selling Clene stock?

Within the last quarter, CLNN stock was sold by these institutional investors:
  1. Lunt Capital Management Inc.

Clene Active Insiders

David J. Matlin
David J. Matlin (Age 63)
Director
Mark Mortenson
Mark Mortenson
Chief Science Officer